Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Antisense oligonucleotides designed at Isis for modulating PKC expression

Jan. 26, 2000

ISIS-3521: phase I trial establishes MTD and supports phase II development

Jan. 25, 2000

New protein prenyltransferase inhibitors from Merck lacking a thiol moiety

Jan. 25, 2000

Pharmacia & Upjohn launches Aromasin breast cancer therapy in the U.S.

Jan. 24, 2000

New findings enhance validity of preclinical models for evaluating LHRH peptide conjugates

Jan. 24, 2000

Takeda reveals new GnRH antagonists in recently issued patent

Jan. 24, 2000

Immunomedics' bispecific fusion proteins covered by U.S. patent

Jan. 24, 2000

NCI to initiate phase III trial of Neovastat in the U.S. and Canada

Jan. 24, 2000

German colorectal cancer patients have new treatment option: Sanofi-Synthelabo's Eloxatin

Jan. 21, 2000

Human Genome Sciences initiates phase II clinical trial of repifermin for mucositis

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...